Skip to main content

Table 1 Antimicrobial susceptibility test results of 1179 S.maltophilia clinical isolates

From: Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro

Antibiotics

Sensitive

Intermediate

Resistant

Non-susceptible rate

Levofloxacin (LVX)

1082

16

81

8.23%

Minocyline (MH)

1142

25

12

3.14%

Sulfamethoxazole (SXT)

1105

21

53

6.28%